Fourth-Generation Chimeric Antigen Receptor T-Cell Therapy is Tolerable and Efficacious in Treatment-Resistant Rheumatoid Arthritis
Rheumatoid Arthritis (RA) is an autoimmune inflammatory disease characterized by symmetric synovitis, leading to progressive functional disability in patients. Although monoclonal antibody therapies targeting cytokines (e.g., tumor necrosis factor-α, TNFα) and B cells (e.g., CD20-targeted antibody rituximab) have significantly improved RA treatment...